WST West Pharmaceutical Services Earnings and EPS analysis

EPS in 2025 (TTM): $6.72

Last Report Period Date: Jun 30, 2025

As of August 2025, WST's current EPS stands at $6.72, according to the latest financial reports. West Pharmaceutical Services's EPS for 2024 amounted to $6.75, marking a drop from $7.98 in 2023. WST reported an EPS of $1.82 for the quarterly report ending on Jun 30, 2025.

WST earnings history

Historical annual and quarterly earnings per share (EPS) data for West Pharmaceutical Services
EPS (TTM)
$6.72
EPS Growth YoY (Quarterly)
19.7%
EPS (Quarterly)
$1.82
EPS Growth (Quarterly)
46.8%

For 2024, West Pharmaceutical Services's EPS was $6.75, a drop of 15.4% from $7.98 in 2023. The quarterly per-share earnings for the period ending Jun 30, 2025, was $1.82, indicating a 19.7% increase from the same quarter last year. WST's 12-month EPS stands at $6.72 as of June 2025. West Pharmaceutical Services's annual EPS in 2023 stood at $7.98, a 1.4% increase year-over-year.

WST EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
19.7%
EPS growth YoY
-15.4%
EPS growth 3Y avg
-8.8%
EPS growth 5Y avg
15.6%

West Pharmaceutical Services has registered an increase in EPS of 19.7% during the last 12 months (YoY, quarterly). In the last three years, WST recorded an average annual EPS growth rate of -8.8%. West Pharmaceutical Services had an average annual EPS growth rate of 15.6% during the last 5 years. Across the last decade, WST had an average annual EPS growth of 14.2%.

WST Earnings Waterfall

Breakdown of revenue, profit and net income for West Pharmaceutical Services

WST Earnings vs Peers

What are the earnings of WST compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
JNJ Johnson & Johnson 18.42 -57.9% -9.7% 0.4%
MDT Medtronic plc 25.59 31% -1.1% 0.3%
TFX Teleflex Inc 27.35 -80.3% -47.6% -31.7%
BDX Becton Dickinson & Co 35.18 18.3% -5.3% 8%
WST West Pharmaceutical Services Inc 35.86 -15.4% -8.8% 15.6%
SYK Stryker Corp 49.36 -5.8% 14.1% 7.1%
ICUI Icu Medical Inc N/A -292.7% N/A N/A
BAX Baxter International Inc N/A -124.2% N/A N/A
PLL Piedmont Lithium Inc N/A -189.5% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.